I pursued medical oncology for my career because of the unique opportunity to provide longitudinal care for patients during their most vulnerable times. Oncology has evolved arguably more rapidly than any other field of medicine in the last couple of decades, and I will help my patients navigate and understand the cutting-edge advances in cancer diagnostics and treatments.
Chao Yin, MDChao Yin, MD earned his medical degree at Georgetown University School of Medicine, Washington D.C. He completed an Internal Medicine Residency at MedStar Georgetown Medical Center followed by a Fellowship in Oncology and Hematology. There, he also served as Chief Fellow.
Dr. Yin joins Virginia Cancer Specialists after completing his fellowship at MedStar Georgetown. During his time there, he participated in various studies, with an emphasis on gastrointestinal (GI) cancers. In his fellowship, he was awarded the Conquer Cancer award at the annual American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) meeting. He has presented posters at national physician conferences, and authored several peer-reviewed publications.
Dr. Yin is a member of several oncology societies including the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO).
In his spare time, Dr. Yin enjoys basketball, board games, and spending time with family.
MedStar Georgetown Medical Center, Clinical Fellow in Oncology and Hematology
Georgetown University School of Medicine
Georgetown University School of Medicine
MedStar Georgetown Medical Center, Resident Physician in Internal Medicine
Duke University, School of Engineering, Bachelor of Science and Engineering in Biomedical Engineering
Gastrointestinal and Thoracic Cancers
Immune checkpoint inhibitors in liver transplant recipients - a review of current literature
Outcome of early and intermediate-stage hepatocellular carcinoma (HCC): A single institution experience at MGUH.
Long-Term Follow-up of Follicular Lymphoma (FL) Patients (pts) Demonstrating Undetectable Minimal Residual Disease (MRD) Using a Next-Generation Based DNA Assay: Support for FL As a Curable Disease
High-grade B-cell lymphoma masquerading as peritoneal lymphomatosis
Read MoreMolecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists
Read MoreMaternal intake of high n-6 polyunsaturated fatty acid diet during pregnancy causes transgenerational increase in mammary cancer risk in mice
Read MorePaternal overweight is associated with increased breast cancer risk in daughters in a mouse model
Read MoreAbstract LB-301: Paternal overweight leads to reprogramming of daughters’ breast cancer risk in a mouse model. Cancer Research.
Read MoreMaternal high fat diet during pregnancy induces similar miRNA changes in F1 generation male germ cells and F3 generation female mammary glands (LB309)
Read MoreAbstract LB-244: Paternal obesity alters daughters' mammary gland development and increases markers of breast cancer risk in a mouse model
Read MoreDestructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion
Read MoreAbstract NO-62: Patterns of treatment and survival of GBM patients with diabetes mellitus
Read MoreSingle-tube analysis of DNA methylation with silica superparamagnetic beads
Read MoreDNA methylation density analysis via fluorescent dye incorporation
Read More
Hours of Operation
Monday through Friday
8:30 a.m. to 5:00 p.m
Phone:
(571) 350-8400
Fax:
(703) 280-9596
Address:
8613 Route 29
Fairfax, VA 22031